Cambridge technology business Checkit plc has signed a three-year contract worth £2.8 million with Biomat USA, Inc., a subsidiary of Grifols S.A.
The value of the contract will be spread evenly over the three years and involve providing services to over 300 sites. This will see AIM-quoted Checkit extend its US footprint within Grifols to initially five of its US subsidiaries.
Of the total contract value, around 12 per cent represents the renewal of existing business with Grifols with the remainder upsell and new business.
Checkit plc provides cloud-based services, supplying intelligent operations management platforms for deskless workforces.
Grifols is a global leader in the production of plasma-derived medicine and transfusion medicines. Headquartered in Spain, it has a worldwide network of over 350 plasma centres including more than 50 in Europe.
With revenues of €5.3 billion (of which €3.6bn was generated from US operations during 2020), Grifols employs 24,000 people, providing products and services in more than 100 countries.
The agreement establishes Checkit as Grifols’ partner of choice for the provision of intelligent operations technology in the US. On top of this, expansion of the Checkit platform to cover Grifols’ key countries of operations in Europe is at advanced stages of discussion.
Additionally, Grifols plans to build 20 plasma centres in Egypt, with Checkit having recently signed a separate three-year contract to provide intelligent operations services to the first 10 of these.
Checkit CEO Kit Kyte said: “We look forward to the continued growth of our relationship internationally. Our partners at Grifols already appreciate the power of our monitoring services and the future addition of workflow management will give them unprecedented levels of digital control and data-driven insight, as we look for ways to streamline their complex, globally distributed operations.
“This deal provides further confirmation of the importance of our technology in enabling intelligent operations across deskless workforces.”